Metabolon

What if you could add functional biological evidence to your genetic discoveries?

Visit the Metabolon team at booth #118 during to learn how metabolomics is helping researchers gain deeper insight from genetic studies.

By connecting genetic findings to functional biology, metabolomics can help researchers:

🔬 Functionally interpret variants, including VUS
🧬 Identify pathway disruptions and disease mechanisms
👥 Improve patient stratification and precision medicine approaches
🔗 Integrate genomics, proteomics, and metabolomics for deeper biological insight

📍 Stop by Booth #118 or reach out to schedule a meeting.

How do you move from measuring biological components to understanding biological function?

Metabolomics provides a unique perspective by capturing the small molecules that directly reflect biological activity, offering insights that complement genomics, transcriptomics, and proteomics.

To help researchers navigate this rapidly growing field, we've updated our Guide to Metabolomics (3rd Edition).

Inside, you'll find:

🔬 An introduction to metabolomics and its role in multiomics research

🧬 Applications across biomarker discovery, drug development, nutrition science, and translational research

📊 Practical guidance for designing metabolomics studies

✨ Expanded content on alternative sample matrices, translational science, and commercial applications

Whether you're new to metabolomics or looking to deepen your expertise, this guide provides a practical foundation for applying metabolomics in modern research.

📖 Download your free copy: https://bit.ly/4xrbC39

How is metabolomics transforming cancer research?

Join our upcoming webinar with Micaiah Ward, Field Metabolomic Scientist at Metabolon, and Patrick Hill, Business Development Executive at Metabolon, to learn how metabolomics can turn biological insights into clinical impact across oncology research.

In this session, you'll learn:

▸Why metabolomics is a game-changer in oncology research

▸Translation of tumor tissue insights into non-invasive biomarkers

▸How metabolomics supports earlier detection and risk assessment

▸Real-world applications across oncology

📅 Wednesday, June 17
🕑 11 am EDT | 4 pm BST

Register today! https://bit.ly/4obHFQp

Women have long shaped the trajectory of discovery in the life sciences, driving advances that continue to transform how we understand biology, disease, and human health.

Today, that legacy continues at Metabolon, where women are helping advance multiomics through leadership in metabolomics, bioinformatics, translational science, laboratory operations, quality systems, and scientific strategy.

In our Women in STEM: Leading the Way in Multiomics series, we're highlighting the Metabolon scientists helping shape the future of biological discovery.

We begin with Dr. Katherine Black, who explains why metabolomics is essential for turning multiomic data into meaningful decisions.

Read Katherine's interview here:

From Multiomic Data to Decisions: Katherine Black, Metabolon Business Development Executive, on the Power of Metabolomics Learn about Katherine Black, Business Development Executive, and the power that multiomics data plays in her role at Metabolon

Are you ?

Don’t forget to join us tomorrow morning for the Metabolon Breakfast Seminar and get an early look at Metabolon Verus™, our new metabolomics profiling kit designed to bring standardized, scalable, and reproducible metabolomics workflows directly into your lab.

📅 Wednesday, June 3
⏰ 7:00 AM
📍 Room 33C

Can't make it in person? Register for the live stream: https://bit.ly/4aaQy6P

We look forward to sharing how Metabolon Verus™ helps researchers accelerate metabolomics studies, from sample extraction to biological insights.

We’re excited to head to hashtag next week in San Diego!

Stop by Booth #820 to learn more about Metabolon Verus™, our new metabolomics kit designed to deliver scalable, reproducible, and insight-driven metabolomics workflows directly into your lab.

Join us for:
🔹 Our breakfast session on Wednesday, June 3 at 7:00 AM (Room 33C)
🔹 Our poster presentation on Wednesday, June 3: Modernizing Metabolomics: A Rugged and Robust Metabolomics Workflow
🔹 Conversations about collaboration, multiomics, and the future of metabolomics

And great giveaways too!🎁

We look forward to seeing the mass spectrometry community in San Diego.

Today marks an exciting milestone for Metabolon.

Our first metabolomics kit is here!

Meet Metabolon Verus™ Metabolomics Profiling Kit.

Built on more than 25 years of metabolomics expertise, Metabolon Verus™ is designed to bring Metabolon’s industry-leading metabolomics capabilities directly into laboratories worldwide.

Researchers will now be able to generate standardized, reproducible metabolomics data in-house through validated workflows, embedded quality controls, automated annotation, and integrated bioinformatics.

We’re excited to showcase Metabolon Verus™ at . Come by our booth ( #820) and breakfast seminar on Wednesday, 3rd June to learn more!

🔗Read full press release here: https://bit.ly/3RvylKR

How can we accelerate progress in understanding and treating GBA1-associated neurodegenerative diseases?

The GBA1 Meeting 2026 in Phoenix, Arizona, will bring together leaders across academia and industry to advance GBA1 research, from basic science to clinical trials.

Greg Michelotti from Metabolon is attending the meeting. If you are there and want to learn more about Metabolon’s work in this space, including our collaboration with The Michael J. Fox Foundation, feel free to connect with him during the conference.

What can deep lipidomics reveal about human disease biology?

New research in Nature Communications used Metabolon’s Complex Lipid Panel to uncover novel genetic links to lipid metabolism and disease pathways, highlighting the power of species-level lipidomics at population scale.

Explore the key findings in the carousel below 👇

And read the full paper here: https://go.nature.com/4f048xk